These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28713969)

  • 1. Downregulation of PTPRH (Sap-1) in colorectal tumors.
    Bujko M; Kober P; Statkiewicz M; Mikula M; Grecka E; Rusetska N; Ligaj M; Ostrowski J; Siedlecki JA
    Int J Oncol; 2017 Sep; 51(3):841-850. PubMed ID: 28713969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.
    Sato T; Soejima K; Arai E; Hamamoto J; Yasuda H; Arai D; Ishioka K; Ohgino K; Naoki K; Kohno T; Tsuta K; Watanabe S; Kanai Y; Betsuyaku T
    Oncol Rep; 2015 Sep; 34(3):1137-45. PubMed ID: 26134684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
    BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening for methylation-silenced genes in colorectal cancer.
    Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
    Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
    He T; Wang C; Zhang M; Zhang X; Zheng S; Linghu E; Guo M
    Discov Med; 2017 Mar; 23(126):155-162. PubMed ID: 28472608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
    Kano H; Takayama T; Midorikawa Y; Nagase H
    Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile.
    Khamas A; Ishikawa T; Shimokawa K; Mogushi K; Iida S; Ishiguro M; Mizushima H; Tanaka H; Uetake H; Sugihara K
    Cancer Genomics Proteomics; 2012; 9(2):67-75. PubMed ID: 22399497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
    Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
    Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of
    Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
    Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
    Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
    Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
    Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
    To KK; Leung WW; Ng SS
    Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.
    González B; Fece de la Cruz F; Samuelsson JK; Alibés A; Alonso S
    Sci Rep; 2018 Jul; 8(1):11097. PubMed ID: 30038405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.